C6orf163

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, C6orf163 mutation is significantly associated with the RNA expression of many other genes, with 63 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible C6orf163-associated genes across cancer lineages are FAM236A, RNA5SP414, and C12orf43. Each is linked with C6orf163 in more than 1 cancer types. Because this analysis shows association rather than direction, both C6orf163-to-partner and partner-to-C6orf163 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (C6orf163→partner) and Y-score (partner→C6orf163) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCAFAM236A →+0.089+9.057<.001.00331
UCECRNA5SP414 →+0.603+2.670.001.00931
UCECC12orf43 →+0.419+3.202.003.00931
UCECCLEC12A →+0.627+3.255<.001.00931
UCECTIMM22 →+0.467+3.223.008.00931
UCECMUL1 →+0.607+3.201.004.00931
Each partner links to its Q-omics profile. Showing the 6 strongest of 63 associations by consensus.

Exploration